Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Atherosclerosis. 2011 May 6;218(1):77–82. doi: 10.1016/j.atherosclerosis.2011.04.028

Figure 3.

Figure 3

Figure 3

A. FPLC Analysis of Rat Serum Serum from normal, hypophysectomized, and hypophysectomized rats treated with T3 were fractionated and assayed for cholesterol in the upper panel. The lower panel displays Western blots for ApoA-I of selected fractions from 26 to 46. B. Supplementation of Hypothyroid Serum with ApoA-I. Efflux assays using serum from Hyphysectomized rats (Hx) supplemented with varying amounts of ApoA-I.